Genprex, Inc. Shares Outstanding (Cover Page)
Genprex, Inc. (GNPX) had Shares Outstanding (Cover Page) of 819.71 thousand shares as of 2026-08-10, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-14
- 2026-08-10: Entity Common Stock, Shares Outstanding 819.71K shares.
- 2026-05-11: Entity Common Stock, Shares Outstanding 10.59M shares.
- 2026-03-27: Entity Common Stock, Shares Outstanding 9.04M shares.
- 2025-11-13: Entity Common Stock, Shares Outstanding 2.27M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-10 | 819.71K shares 10-Q · filed 2026-08-14 |
| 2026-05-11 | 10.59M shares 10-Q · filed 2026-05-13 |
| 2026-03-27 | 9.04M shares 10-K · filed 2026-03-30 |
| 2025-11-13 | 2.27M shares 10-Q · filed 2025-11-14 |
| 2025-08-01 | 33.47M shares 10-Q · filed 2025-08-14 |
| 2025-05-09 | 27.82M shares 10-Q · filed 2025-05-12 |
| 2025-03-28 | 24.15M shares 10-K · filed 2025-04-01 |
| 2024-11-05 | 8.51M shares 10-Q · filed 2024-11-13 |
| 2024-08-05 | 2.59M shares 10-Q · filed 2024-08-09 |
| 2024-05-07 | 2.10M shares 10-Q · filed 2024-05-15 |
| 2024-03-25 | 1.91M shares 10-K · filed 2024-04-01 |
| 2023-11-06 | 59.43M shares 10-Q · filed 2023-11-14 |
| 2023-08-10 | 59.41M shares 10-Q · filed 2023-08-21 |
| 2023-05-10 | 51.98M shares 10-Q · filed 2023-05-22 |
| 2023-03-15 | 51.97M shares 10-K · filed 2023-03-31 |
| 2022-11-08 | 48.03M shares 10-Q · filed 2022-11-14 |
| 2022-08-05 | 48.02M shares 10-Q · filed 2022-08-12 |
| 2022-05-10 | 47.90M shares 10-Q · filed 2022-05-13 |
| 2022-03-15 | 47.88M shares 10-K · filed 2022-03-30 |
| 2021-11-08 | 47.81M shares 10-Q · filed 2021-11-15 |
| 2021-08-10 | 47.53M shares 10-Q · filed 2021-08-13 |
| 2021-05-10 | 47.36M shares 10-Q · filed 2021-05-17 |
| 2021-03-15 | 43.28M shares 10-K · filed 2021-03-26 |
| 2020-11-06 | 39.62M shares 10-Q · filed 2020-11-12 |
| 2020-08-07 | 38.87M shares 10-Q · filed 2020-08-11 |
| 2020-05-11 | 32.85M shares 10-Q · filed 2020-05-14 |
| 2020-03-27 | 32.85M shares 10-K · filed 2020-03-30 |
| 2019-11-01 | 15.85M shares 10-Q · filed 2019-11-14 |
| 2019-08-07 | 15.84M shares 10-Q · filed 2019-08-13 |
| 2019-05-10 | 15.60M shares 10-Q/A · filed 2019-05-20 |
| 2019-03-25 | 15.54M shares 10-K · filed 2019-04-01 |
| 2018-11-12 | 15.07M shares 10-Q · filed 2018-11-14 |
| 2018-08-14 | 15.07M shares 10-Q · filed 2018-08-14 |
| 2018-05-15 | 13.90M shares 10-Q · filed 2018-05-15 |
| 2018-04-06 | 13.04M shares 10-K · filed 2018-04-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |